Ampio Pharmaceuticals Inc Watch

from S-3 44 pages At the Market Offering Agreement September 18, 2023

from 8-K 2 pages Ampio Pharmaceuticals, Inc. (A Delaware Corporation) Amendment No. 1 to Underwriting Agreement

from 8-K 32 pages Ampio Pharmaceuticals, Inc. (A Delaware Corporation) 20,000,000 Shares of Common Stock and Warrants to Purchase Up to 20,000,000 Shares of Common Stock Underwriting Agreement

from 8-K 42 pages Ampio Pharmaceuticals, Inc. 8,500,000 Shares Common Stock ($0.0001 Par Value) Plus an Option to Purchase From the Company Up to 1,275,000 Additional Shares of Common Stock Underwriting Agreement

from 8-K 3 pages Underwriters Underwriters Total Number of Firm Stock to Be Purchased Number of Additional Stock to Be Purchased if the Over-Allotment Option Is Fully Exercised Aegis Capital Corp. 4,748,684 685,387 Fordham Financial Management, Inc. 47,966 6,923 Total 4,796,650 692,310

from 8-K 40 pages 4,615,400 Shares of Common Stock Ampio Pharmaceuticals, Inc. Underwriting Agreement

from S-1 11 pages Escrow Agreement

from S-1 16 pages Ampio Pharmaceuticals Inc., a Delaware Corporation (The “Company”), Confirms Its Agreement With Fordham Financial Management, Inc., a Colorado Corporation (The “Placement Agent”), With Respect to the Sale by the Company of Up to 4,400,0000 Shares of Common Stock (The “Shares”) at an Offering Price of $2.50 Per Share (The “Purchase Price”) to Be Offered for Sale Pursuant to a Confidential Private Placement Memorandum Dated March 21, 2011 (The “Memorandum”) to Be Provided to Investors. the Company and the Placement Agent Reserve the Right to Increase the Size of the Offering at Any Time Without Notice to Subscribers or Investors, on Consent of the Placement Agent. the Memorandum Shall Include All Documents Which Are Incorporated by Reference Into the Memorandum. Section 1. Best Efforts Offering